Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,121Revenue $M263Net Margin (%)-8.3Z-Score4.8
Enterprise Value $M1,084EPS $-0.3Operating Margin %-7.7F-Score3
P/E(ttm))0Cash Flow Per Share $0.0Pre-tax Margin (%)-8.0Higher ROA y-yN
Price/Book6.010-y EBITDA Growth Rate %0Quick Ratio1.9Cash flow > EarningsY
Price/Sales3.85-y EBITDA Growth Rate %0Current Ratio2.9Lower Leverage y-yN
Price/Cash Flow364y-y EBITDA Growth Rate %-53.3ROA % (ttm)-7.9Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-12.7Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M62.0ROI % (ttm)-7.0Gross Margin Increase y-yY

Gurus Latest Trades with NXTM

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
NXTMJohn Burbank 2012-12-31 Sold Out -0.09%$10.61 - $13.73
($11.63)
$ 18.0956%Sold Out0
NXTMJohn Burbank 2012-09-30 Buy 0.09%$12.47 - $17.04
($14.28)
$ 18.0927%New holding, 150000 sh.150,000
NXTMRon Baron 2012-06-30 Sold Out -0.02%$14.94 - $19.44
($16.42)
$ 18.0910%Sold Out0
NXTMRon Baron 2012-03-31 Buy 0.02%$16.55 - $21.54
($17.89)
$ 18.091%New holding, 176418 sh.176,418
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NXTM is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


NXTM: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Swan Winifred LSVP and General Counsel 2014-12-18Sell500$18.25-0.88view
Turk Joseph E JrPresident 2014-12-15Sell2,000$17.453.67view
Hershberger KevinChief Accounting Officer 2014-12-15Sell8,000$17.195.24view
Turk Joseph E JrPresident 2014-12-10Sell1,500$17.771.8view
Burbank Jeffrey HCEO 2014-12-05Sell5,000$17.165.42view
Brown Robert S.President, Kidney Care 2014-12-03Sell300$17.483.49view
Brown Robert S.President, Kidney Care 2014-12-02Sell34,700$17.443.73view
Turk Joseph E JrPresident 2014-12-01Sell24,762$17.046.16view
Swan Winifred LSVP and General Counsel 2014-12-01Sell16,667$17.046.16view
Turk Joseph E JrPresident 2014-11-25Sell3,350$17.592.84view

Press Releases about NXTM :

    Quarterly/Annual Reports about NXTM:

    News about NXTM:

    Articles On GuruFocus.com
    Weekly 3-Year Low Highlights: MFLX, NXTM, CVRR, CMLP Nov 10 2013 
    NxStage Medical Inc. (NXTM) President & CEO Jeffrey H Burbank sells 20,000 Shares Mar 18 2011 
    NxStage Medical Inc. (NXTM) Sr. Vice President, CFO Robert S. Brown sells 15,000 Shares Mar 18 2011 
    NxStage Medical Inc. (NXTM) Sr. Vice President, CFO Robert S. Brown sells 15,000 Shares Feb 18 2011 
    NxStage Medical Inc. (NXTM) President & CEO Jeffrey H Burbank sells 20,000 Shares Feb 18 2011 
    NxStage Medical Inc. (NXTM) President & CEO Jeffrey H Burbank sells 20,000 Shares Jan 21 2011 
    NxStage Medical Inc. (NXTM) Sr. Vice President, CFO Robert S. Brown sells 15,000 Shares Jan 20 2011 
    NxStage Medical Inc. (NXTM) President & CEO Jeffrey H Burbank sells 13,710 Shares Dec 17 2010 
    NxStage Medical Inc. (NXTM) Sr. Vice President, CFO Robert S. Brown sells 12,000 Shares Dec 16 2010 
    NxStage Medical Inc. (NXTM) President & CEO Jeffrey H Burbank sells 13,710 Shares Dec 16 2010 

    More From Other Websites
    NxStage Founder and CEO Discusses Innovation in Healthcare at EY Boston Life Sciences Summit Dec 19 2014
    NxStage Founder and CEO Discusses Innovation in Healthcare at EY Boston Life Sciences Summit Dec 19 2014
    NxStage to Present at the 33rd Annual J.P. Morgan Healthcare Conference Dec 18 2014
    NxStage to Present at the 33rd Annual J.P. Morgan Healthcare Conference Dec 18 2014
    NXSTAGE MEDICAL, INC. Files SEC form 8-K, Change in Directors or Principal Officers Nov 26 2014
    NxStage Medical (NXTM) Upgraded From Sell to Hold Nov 26 2014
    NxStage Medical Unveils Streamline Express Dialyzer Nov 21 2014
    NxStage Launches New Streamline Express Dialyzer With Pre-attached Blood Tubing Set Nov 18 2014
    NxStage Launches New Streamline Express Dialyzer With Pre-attached Blood Tubing Set Nov 18 2014
    NXSTAGE MEDICAL, INC. Financials Nov 14 2014
    New Data Demonstrates Significant Advantage in Mortality, Hospitalization, and Patient Dropout with... Nov 11 2014
    10-Q for NxStage Medical, Inc. Nov 09 2014
    NXSTAGE MEDICAL, INC. Files SEC form 10-Q, Quarterly Report Nov 07 2014
    NxStage Announces Fourth Quarter 2014 Investor Conference Schedule Nov 07 2014
    NxStage Announces Fourth Quarter 2014 Investor Conference Schedule Nov 07 2014
    NxStage Reports Record Third Quarter 2014 Financial Results And Raises Full-Year Revenue Guidance Nov 06 2014
    NXSTAGE MEDICAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Nov 06 2014
    NxStage Reports Record Third Quarter 2014 Financial Results And Raises Full-Year Revenue Guidance Nov 06 2014
    Q3 2014 NxStage Medical Inc Earnings Release - Before Market Open Nov 06 2014
    NxStage Announces Winner of First Annual Nurse Hero Campaign Nov 04 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK